Peter Calabresi
Peter Calabresi
Verified email at
Cited by
Cited by
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
L Kappos, EW Radue, P O'Connor, C Polman, R Hohlfeld, P Calabresi, ...
New England Journal of Medicine 362 (5), 387-401, 2010
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ...
New England Journal of Medicine 354 (9), 911-923, 2006
Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification
K Hua, J Zhang, S Wakana, H Jiang, X Li, DS Reich, PA Calabresi, ...
Neuroimage 39 (1), 336-347, 2008
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double‐blind placebo‐controlled multicenter trial
K Hawker, P O'Connor, MS Freedman, PA Calabresi, J Antel, J Simon, ...
Annals of neurology 66 (4), 460-471, 2009
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ...
The Lancet 378 (9805), 1779-1787, 2011
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis
JB Fisher, DA Jacobs, CE Markowitz, SL Galetta, NJ Volpe, ...
Ophthalmology 113 (2), 324-332, 2006
Saccade preparation inhibits reorienting to recently attended locations.
RD Rafal, PA Calabresi, CW Brennan, TK Sciolto
Journal of Experimental Psychology: Human Perception and Performance 15 (4), 673, 1989
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
PA Calabresi, EW Radue, D Goodin, D Jeffery, KW Rammohan, AT Reder, ...
The Lancet Neurology 13 (6), 545-556, 2014
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled …
L Kappos, G Comi, H Panitch, J Oger, J Antel, P Conlon, L Steinman, ...
Nature medicine 6 (10), 1176-1182, 2000
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
A Petzold, JF de Boer, S Schippling, P Vermersch, R Kardon, A Green, ...
The Lancet Neurology 9 (9), 921-932, 2010
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA
SS Soldan, R Berti, N Salem, P Secchiero, L Flamand, PA Calabresi, ...
Nature medicine 3 (12), 1394-1397, 1997
Kv1. 3 channels are a therapeutic target for T cell-mediated autoimmune diseases
C Beeton, H Wulff, NE Standifer, P Azam, KM Mullen, MW Pennington, ...
Proceedings of the National Academy of Sciences 103 (46), 17414-17419, 2006
Rituximab in relapsing‐remitting multiple sclerosis: a 72‐week, open‐label, phase I trial
A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ...
Annals of neurology 63 (3), 395-400, 2008
The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
H Wulff, PA Calabresi, R Allie, S Yun, M Pennington, C Beeton, ...
The Journal of clinical investigation 111 (11), 1703-1713, 2003
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
F Barkhof, PA Calabresi, DH Miller, SC Reingold
Nature Reviews Neurology 5 (5), 256-266, 2009
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
E Gordon-Lipkin, B Chodkowski, DS Reich, SA Smith, M Pulicken, ...
Neurology 69 (16), 1603-1609, 2007
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
A Bar‐Or, L Fawaz, B Fan, PJ Darlington, A Rieger, C Ghorayeb, ...
Annals of neurology 67 (4), 452-461, 2010
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis
LS Talman, ER Bisker, DJ Sackel, DA Long Jr, KM Galetta, JN Ratchford, ...
Annals of neurology 67 (6), 749-760, 2010
Optical coherence tomography: a window into the mechanisms of multiple sclerosis
EM Frohman, JG Fujimoto, TC Frohman, PA Calabresi, G Cutter, ...
Nature clinical practice Neurology 4 (12), 664-675, 2008
The system can't perform the operation now. Try again later.
Articles 1–20